Flyer Biotechnology & Pharmaceuticals - Invest in Saxony-Anhalt

denunequaledBiotechnology

Dec 1, 2012 (4 years and 4 months ago)

237 views

Biotechnology &
Pharmaceuticals
Bio-Zentrum Halle GmbH · EBG GmbH · Icon Genetics GmbH · IDT Biologika GmbH · IMTM GmbH · Kanzlei Gulde, Hengelhaupt & Co. · Leibniz Institute of Plant Genetics and Crop Plant Research
Gatersleben · Nomad Life Sciences GmbH · Nordsaat Saatzucht GmbH · Probiodrug AG · SunGene GmbH · TraitGenetics GmbH · Zenit GmbH · Biotech-Gründerzentrum Gatersleben GmbH
Biotechpark Gatersleben GmbH · City Dessau-Roßlau · City Halle · City Seeland · Dr. Felgenträger & Co. Öko.-chem. und Pharma GmbH · GfW Aschersleben-Staßfurt mbH · Gicon GmbH
InnoPlanta - Plant Biotechnology Nordharz / Börde e.V. · Leibniz Institute of Neurobiology · Leibniz Institute of Plant Biochemistry · Martin Luther University Halle-Wittenberg · Merz Group Services
Max Planck Institute of Dynamics of Complex Technical Systems · Ontochem GmbH · Orgentis Chemicals GmbH · Otto von Guericke University Magdeburg · ProNet T3 · Pumacy Technologies AG
Pupils Lab „Grünes Labor Gatersleben“ e.V. · Saaten Union Biotec GmbH · Salutas Pharma GmbH · TGZ Halle GmbH · Univations GmbH · University of Applied Studies Anhalt
State Capital Magdeburg
City of Dessau-Roßlau
Vaccine Technology
Development & Manufacturing of
Biological and Pharmaceutical Products
Quality Control & Compliance
Gatersleben
Plant Genetics
Marker‐Assisted Breeding
Crop Plant Research
City of Halle
Biopharmaceuticals
Biopolymeres
Recombinant Protein Engineering
Biopharming
Airport
Leipzig/Halle
Location
· 60 Biotech and Pharmaceutical Companies
· 6,300 Employees, 1.5 billion Euro turnover
· 2 Universities, 3 Universities of Applied Sciences,
10 Research Institutes (e.g. Max-Planck, Leibniz, Fraunhofer, Leopoldina, Helmholtz)
· Lead Investors: Bayer, BASF, Merz, Sandoz/Novartis, IDT, Dow
· Topics: Therapies & Diagnostics, Biopharmaceuticals, Agri Business
300 miles
600 miles
1,200 miles
Neurodegenerative Diseases
and General Neuro Sciences
Inflammation & Autoimmune
Diseases
Clinical Trials
Generic Production
State-of-the-art
Logistics Hub
Dr. Michael Taeger, CEO, IMTM GmbH:
„Biopharmaceutical innovation is an essential component of the
future development across society. Due to the unique combination
of best economic and excellent scientfic conditions, Saxony-Anhalt
offers outstanding opportunities for biotech companies based here
to realize most ambitious goals.“
Investment and Marketing Corporation Saxony-Anhalt
The Economic Development Agency
of the German Federal State of Saxony-Anhalt
Managing Director: Dr. Carlhans Uhle
Investment and Marketing Corporation Saxony-Anhalt mbH (IMG) is the
business location service and marketing agency of Saxony-Anhalt.
IMG staff provides all BLS services – from acquisition to production start.
IMG is also globally marketing the business and science location and
developing touristic concepts. Saxony-Anhalt‘s government is the sole
IMG shareholder.
Your partner for:
1. site selection
2. subsidy and financing issues
3. permitting assistance
4. full line project management
For further information please visit: www.invest-in-saxony-anhalt.com
BIO Mitteldeutschland GmbH
An Association of Companies and Research Institutes
in the Field of Biotechnology and Pharmaceutical Industry in Saxony-Anhalt
Managing Director: Dr. Michael Täger
BIO Mitteldeutschland GmbH’s (BMD) aim is to provide
customer-oriented support to companies and research institutions
in the Life Sciences with an integrated package of diverse activities
to foster successful business models and sustainable growth – also by
actively communicating the positive development of Saxony-Anhalt
and all the players involved.
Your partner for:
1. business development
2. technology transfer
3. regulatory affairs adviser
4. networking
For further information please visit: www.biomitteldeutschland.com
Quality and Innovation
Made in Germany. The label for high-technology receives
a great deal of momentum from Saxony-Anhalt.
Flexibility
Short approval and project implementation periods will
fast-track your market entry.
Investment Safety
Political and financial stability make Saxony-Anhalt
a reliable investment partner for the future.
Productivity
The highest labour-productivity growth in the processing industries
within Germany and moderate unit labour costs plus a stable and
secure legal system give you a decisive competitive advantage.
Investment Incentives
Prime public financial assistance programs will
tangibly reduce your capital and training expenditures.
Nico Horn
Senior Manager
Tel. +49 (0) 391 568 9928
nico.horn@img-sachsen-anhalt.de
Dr. Ullrich Pigla
Manager Biopharma
Tel. +49 (0) 345 279 8355
pigla@biomitteldeutschland.de
YOUR PARTNERS
YOUR LOCATI ON FOR THE FUTURE
IMPRINT Published by: Investment and Marketing Corporation Saxony-Anhalt; Concept and layout: BIO Mitteldeutschland GmbH in cooperation with INSIDE Grafik, Halle;
Picture credits: Investment and Marketing Corporation Saxony-Anhalt, BIO Mitteldeutschland GmbH, IDT Biologika GmbH; editorial deadline: 4/1/2012; 2nd edition;
Subject to changes: The utilization of material for the commercial purpose of selling addresses to third parties or reproduction – in whole or in part – is strictly prohibited.
Industrial turnover in Saxony-Anhalt in relation to Germany
(January 2008 = 100; main industries with 50 and more employees/company;
reference: destatis, calculations made by Nord/LB, adapted)

Jan Mar May Jul Sep Nov Jan Mar May Jul Sep Nov
2009
2010
Jan Mar May
2011
120
100
80
Germany
Saxony-Anhalt
VI SIT US NOW - IT´S JUST THE RI GHT TI ME!